Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
61,151.04 +337.94 (+0.56%) CMC Crypto 200
1,261.13 -96.88 (-7.13%)
Catheter Precision, Inc. (VTAK)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 03:57PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.54M |
| Enterprise value | 1.35M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.46 |
| Price/book (mrq) | 0.21 |
| Enterprise value/revenue | -320.80 |
| Enterprise value/EBITDA | 0.27 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -50.41% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 1.3200 |
| 52-week low 3 | 0.3400 |
| 50-day moving average 3 | 0.5196 |
| 200-day moving average 3 | 0.4852 |
Share statistics
| Avg vol (3-month) 3 | 37.54k |
| Avg vol (10-day) 3 | 40.32k |
| Shares outstanding 5 | 7.57M |
| Implied shares outstanding 6 | 7.57M |
| Float 8 | 5.76M |
| % held by insiders 1 | 17.31% |
| % held by institutions 1 | 5.76% |
| Shares short (30 Apr 2024) 4 | 25.56k |
| Short ratio (30 Apr 2024) 4 | 0.64 |
| Short % of float (30 Apr 2024) 4 | 0.39% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.34% |
| Shares short (prior month 28 Mar 2024) 4 | 17.55k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 17 Nov 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:50 |
| Last split date 3 | 03 Oct 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,190.24% |
Management effectiveness
| Return on assets (ttm) | -15.36% |
| Return on equity (ttm) | -25.18% |
Income statement
| Revenue (ttm) | 439k |
| Revenue per share (ttm) | 0.07 |
| Quarterly revenue growth (yoy) | -3.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -8.25M |
| Net income avi to common (ttm) | -6.85M |
| Diluted EPS (ttm) | -12.9900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.49M |
| Total cash per share (mrq) | 0.2 |
| Total debt (mrq) | 254k |
| Total debt/equity (mrq) | 1.37% |
| Current ratio (mrq) | 0.83 |
| Book value per share (mrq) | 2.45 |
Cash flow statement
| Operating cash flow (ttm) | -10.51M |
| Levered free cash flow (ttm) | -5.71M |
© 2024 Yahoo. All rights reserved.